Table 2.
The incidence of CM and all-cause mortality among CrAg+ and CrAg- persons, and among persons with and without antifungal therapy
| Number of reported studies | Number of persons | ES (95%CI) | I2 | P | |
|---|---|---|---|---|---|
| Incidence of CM among CrAg + persons | |||||
| 1.1 Incidence of CM among CrAg+ persons | 6 | 2118 | 0.03 (0.01, 0.05) | 62.3% | 0.021 |
| Incidence of CM among persons with and without antifungal therapy | |||||
| 2.1 Incidence of CM among persons with antifungal therapy | 6 | 1088 | 0.03 (0.01, 0.06) | 57.7% | 0.037 |
| 2.2 Incidence of CM among persons without antifungal therapy | 4 | 1092 | 0.05 (0.02, 0.09) | 71.5% | 0.015 |
| All-cause mortality in CrAg+ persons | |||||
| 1.1 All-cause mortality among CrAg+ persons | 8 | 2265 | 0.14 (0.06, 0.22) | 94.5% | 0.000 |
| All-cause mortality among persons who with and without antifungal therapy | |||||
| 2.1 All-cause mortality among persons with antifungal therapy | 6 | 396 | 0.17 (0.11, 0.24) | 58.3% | 0.035 |
| 2.2 All-cause mortality among persons without antifungal therapy | 4 | 1092 | 0.10 (0.01, 0.19) | 93.2% | 0.000 |